Yael Hayon - VP, Research & Development at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Research & Development
Stock Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Yael Hayon since 8/21/2023

Holdings reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35.1K $49.5K $1.41 Aug 15, 2023 By Trust
Stock Options (Right to Buy) 35.1K Aug 15, 2023 Direct Common Stock

Transactions reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.